Insider Transactions in Q3 2021 at La Jolla Pharmaceutical CO (LJPC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
182
+3.28%
|
$546
$3.39 P/Share
|
|
Sep 30
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338
+7.88%
|
$1,014
$3.39 P/Share
|
|
Sep 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
546
+9.52%
|
$1,638
$3.39 P/Share
|
|
Sep 15
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338
+8.55%
|
$1,014
$3.39 P/Share
|
|
Aug 31
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
320
+8.89%
|
$960
$3.58 P/Share
|
|
Aug 13
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
338
+10.25%
|
$1,014
$3.38 P/Share
|
|
Jul 30
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
201
+4.15%
|
$603
$3.07 P/Share
|
|
Jul 30
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
374
+12.49%
|
$1,122
$3.07 P/Share
|
|
Jul 15
2021
|
Larry G. Edwards Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
358
+13.75%
|
$1,074
$3.2 P/Share
|
|
Jul 15
2021
|
Michael S Hearne Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
193
+4.16%
|
$579
$3.2 P/Share
|